Dynamic combined monitoring of SII and PNI in evaluating the prognostic impact on advanced driver gene–negative NSCLC patients receiving immunotherapy. This is an ASCO Meeting Abstract from the 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results